Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Vanassche

Showing results (11-20 of 145) with videos related to

Pageof 15
Sort By:
Thrombosis Journal|February 5, 2015
Venous thromboembolism in the elderly: efficacy and safety of non-VKA oral anticoagulantsVincent Geldhof, Christophe Vandenbriele, Peter Verhamme, et al.
Hemasphere|June 5, 2025
New horizons in the pharmacological management of venous thromboembolismAndreas Verstraete, Quentin Van Thillo, Thomas Vanassche, et al.
Thrombosis and Haemostasis|September 5, 2014
Organ-specific bleeding patterns of anticoagulant therapy: lessons from clinical trialsThomas Vanassche, Jack Hirsh, John W Eikelboom, et al.
Journal of Thrombosis and Thrombolysis|November 9, 2013
Rivaroxaban for the treatment of consumptive coagulopathy associated with a vascular malformationChristophe Vandenbriele, Thomas Vanassche, Marijke Peetermans, et al.
Critical Reviews in Microbiology|October 21, 2015
Bacterial pathogens activate plasminogen to breach tissue barriers and escape from innate immunityMarijke Peetermans, Thomas Vanassche, Laurens Liesenborghs, et al.
Expert Review of Cardiovascular Therapy|November 29, 2014
Monitoring and reversal strategies for new oral anticoagulantsSophie Vanden Daelen, Marijke Peetermans, Thomas Vanassche, et al.
Journal of Visualized Experiments : Jove|July 2, 2015
In Vitro and In Vivo Model to Study Bacterial Adhesion to the Vessel Wall Under Flow ConditionsJorien Claes, Laurens Liesenborghs, Marleen Lox, et al.
International Journal of Cardiology|October 19, 2019
The 2013 ACC/AHA risk score and subclinical cardiac remodeling and dysfunction: Complementary in cardiovascular disease predictionNicholas Cauwenberghs, Kristofer Hedman, Yukari Kobayashi, et al.
Journal of Clinical Microbiology|September 3, 2010
Dabigatran inhibits Staphylococcus aureus coagulase activityThomas Vanassche, Jan Verhaegen, Willy E Peetermans, et al.
Expert Review of Cardiovascular Therapy|September 22, 2011
Anti-thrombotic therapy in infective endocarditisThomas Vanassche, Willy E Peetermans, Marie-Christine Herregods, et al.
Pageof 15

Showing results (11-20 of 145) with videos related to

Sort By:
Pageof 15
Thrombosis Journal|February 5, 2015
Venous thromboembolism in the elderly: efficacy and safety of non-VKA oral anticoagulantsVincent Geldhof, Christophe Vandenbriele, Peter Verhamme, et al.
Hemasphere|June 5, 2025
New horizons in the pharmacological management of venous thromboembolismAndreas Verstraete, Quentin Van Thillo, Thomas Vanassche, et al.
Thrombosis and Haemostasis|September 5, 2014
Organ-specific bleeding patterns of anticoagulant therapy: lessons from clinical trialsThomas Vanassche, Jack Hirsh, John W Eikelboom, et al.
Journal of Thrombosis and Thrombolysis|November 9, 2013
Rivaroxaban for the treatment of consumptive coagulopathy associated with a vascular malformationChristophe Vandenbriele, Thomas Vanassche, Marijke Peetermans, et al.
Critical Reviews in Microbiology|October 21, 2015
Bacterial pathogens activate plasminogen to breach tissue barriers and escape from innate immunityMarijke Peetermans, Thomas Vanassche, Laurens Liesenborghs, et al.
Expert Review of Cardiovascular Therapy|November 29, 2014
Monitoring and reversal strategies for new oral anticoagulantsSophie Vanden Daelen, Marijke Peetermans, Thomas Vanassche, et al.
Journal of Visualized Experiments : Jove|July 2, 2015
In Vitro and In Vivo Model to Study Bacterial Adhesion to the Vessel Wall Under Flow ConditionsJorien Claes, Laurens Liesenborghs, Marleen Lox, et al.
International Journal of Cardiology|October 19, 2019
The 2013 ACC/AHA risk score and subclinical cardiac remodeling and dysfunction: Complementary in cardiovascular disease predictionNicholas Cauwenberghs, Kristofer Hedman, Yukari Kobayashi, et al.
Journal of Clinical Microbiology|September 3, 2010
Dabigatran inhibits Staphylococcus aureus coagulase activityThomas Vanassche, Jan Verhaegen, Willy E Peetermans, et al.
Expert Review of Cardiovascular Therapy|September 22, 2011
Anti-thrombotic therapy in infective endocarditisThomas Vanassche, Willy E Peetermans, Marie-Christine Herregods, et al.
Pageof 15